期刊文献+

microRNA在口腔鳞癌中的研究进展 被引量:4

Review on the role of microRNA in Oral squamous cell carcinoma(OSCC)
原文传递
导出
摘要 口腔鳞状细胞癌(OSCC)是口腔颌面部恶性肿瘤中最主要的一类,约占80%以上,好发于男性,但近年来女性的发病率也呈现逐年增加的趋势;microRNA,是一类稳定的短序列非编码RNA,其主要功能是在转录后水平参与靶基因的调控,近来研究已发现在OSCC患者中存在许多异常表达的microRNAs,而这些分子在OSAS的发生发展中扮演着重要的角色,异常的microRNA同样对OSCC的临床诊断、治疗以及判断预后都有着重要的作用;本文对当前microRNA在OSCC中的的异常表达、作用机制以及作为诊断标记物、治疗靶点的潜能进行了综述。 Oral squamous cell carcinoma (OSCC) is one of the most common cancers worldwide about 80%, and it primarily affected male population, but the incidence of OSCC in women was increased recently. MicroRNAs (miRNAs) are small noncoding RNAs that post-transcriptionally modulate gene expression by degrading or repressing the translation of target messenger RNAs (mRNA). Aberrant miRNA expression has been reported in OSCC, and this altered expression may be useful for the early detection of oral cancer. In this review we highlight the miRNAs profile of OSCC, mechanisms, and the potential of being diagnostic markers or therapeutic targets in OSAS.
出处 《现代生物医学进展》 CAS 2014年第16期3163-3166,共4页 Progress in Modern Biomedicine
基金 国家自然基金面上项目(81170938) 甘肃省自然科学基金项目(1208RJZA263) 全军医学科研"十二五"计划项目(CWS12J066)
关键词 口腔鳞状细胞癌 微小RNA Oral squamous cell carcinoma MicroRNA
  • 相关文献

参考文献32

  • 1De Camargo Cancela M, Voti L, Guerra-Yi M, et al. Oral cavity cancer in developed and in developing countries: population-based incidence [J]. Head Neck, 2010, 32(3): 357-367.
  • 2Funk GF, Karnell LH, Robinson RA, et al. Presentation, treatment, and outcome of oral cavity cancer: a National Cancer Data Base report[J]. Head Neck, 2002, 24(2): 165-180.
  • 3Soga D, Yoshiba S, Shiogama S, et al. microRNA expression profiles in oral squamous cell carcinoma[J]. Oncol Rep, 2013, 30(2): 579-583.
  • 4Siow M, Karen Ng L, Vincent Chong V, et al. Dysregulation of miR-31 and miR-375 expression is associated with clinical outcomes in oral carcinoma[J]. Oral Dis, 2013.
  • 5Wang W, Songlin P, Sun Y, et al. miR-21 inhibitor sensitizes human OSCC cells to cisplatin[J]. Mol Biol Rep, 2012, 39(5): 5481-5485.
  • 6Cervigne NK, Reis PP, Machado J, et al. Identification ofa microRNA signature associated with progression of leukoplakia to oral carcino- ma[J]. Hum Mol Genet, 2009, 18(24): 4818-4829.
  • 7Lin SC, Liu CJ, Lin JA, et al. miR-24 up-regulation in oral carcinoma: positive association from clinical and in vitro analysis[J]. Oral Oncol, 2010, 46(3): 204-208.
  • 8Chang KW, Liu C J, Chu TH, et al. Association between high miR-211 microRNA expression and the poor prognosis of oral carcinoma [J]. J Dent Res, 2008, 87(11): 1063-1068.
  • 9Liu C J, Kao SY, Tu HF, et al. Increase of microRNA miR-31 level in plasma could be a potential marker of oral cancer [J]. Oral Dis, 2010, 16(4): 360-364.
  • 10Rather MI, Nagashri MN, Swamy SS, et al. Oncogenic microRNA-155 down-regulates tumor suppressor CDC73 and promotes oral squa- mous cell carcinoma cell proliferation: implications for cancer thera- peutics[J]. J Biol Chem, 2013, 288(1): 608-618.

二级参考文献4

  • 1Chen YK, Hsuen SS, Lin LM. Increased expression of inducible nitric oxide synthase for human oral submucous fibrosis, verrucous hyperplasia,and verrucous carcinoma [ J ]. Int J Oral Maxillofac Surg,2002,31 (4) :419.
  • 2Jinga DC,Blidaru A, Condrea I,et al. MMP-9 and MMP-2 gelatinases and TIMP-1 and TIMP-2 inhibitors in breast cancer: Correlations with prognostic factors [ J ]. J Cell Mol Med, 2006. 10 (2) :499.
  • 3Ashida K, Nakatsukasa H, Higashi T, et al. Cellular distribution of 92-kD type collagenase/gelatinase Bin human hepato cellular carcinoma[ J]. Am J Pathol, 1996,149( 6 ) : 1803 - 1811.
  • 4Shirabe K, Shimada M, Kajiyama K, et al. Expression of matrix metall-oproteinase - 9 ( MMP-9 ) in surgically resected in trahepatic cholangio carcinoma[ J ]. Surgery, 1999,126 ( 5 ) :842 2 846.

共引文献9

同被引文献13

引证文献4

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部